(9R)-9-chloro-11-17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10-13-16-trimethyl-6-7-8-11-12-14-15-16-octahydrocyclopenta[a]phenanthren-3-one and Laryngismus

(9R)-9-chloro-11-17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10-13-16-trimethyl-6-7-8-11-12-14-15-16-octahydrocyclopenta[a]phenanthren-3-one has been researched along with Laryngismus* in 1 studies

Other Studies

1 other study(ies) available for (9R)-9-chloro-11-17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10-13-16-trimethyl-6-7-8-11-12-14-15-16-octahydrocyclopenta[a]phenanthren-3-one and Laryngismus

ArticleYear
Paradoxical bronchospasm and cutaneous rash after metered-dose inhaled bronchodilators.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 1996, Volume: 51, Issue:3

    The authors describe a case of paradoxical bronchospasm with laryngospasm and cutaneous rash occurring in an asthmatic woman after the use, via metered-dose inhaler, of different bronchodilators containing soy-derived excipients. It is noteworthy that the patient was not affected by soy allergy. After a short review of the relevant literature, the authors consider the possible aetiopathogenetic factors and outline the importance of this rare adverse reaction in the care of asthmatic patients.

    Topics: Aerosols; Albuterol; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bronchial Spasm; Bronchodilator Agents; Drug Eruptions; Excipients; Female; Fenoterol; Glycine max; Humans; Ipratropium; Laryngismus; Middle Aged; Nebulizers and Vaporizers

1996